학술논문
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial
Document Type
Article
Author
Landovitz, Raphael J ; Hanscom, Brett S; Clement, Meredith E; Tran, Ha V; Kallas, Esper G; Magnus, Manya; Sued, Omar; Sanchez, Jorge; Scott, Hyman; Eron, Joe J; del Rio, Carlos; Fields, Sheldon D; Marzinke, Mark A; Eshleman, Susan H; Donnell, Deborah; Spinelli, Matthew A; Kofron, Ryan M; Berman, Richard; Piwowar-Manning, Estelle M; Richardson, Paul A; Sullivan, Philip A; Lucas, Jonathan P; Anderson, Peter L; Hendrix, Craig W; Adeyeye, Adeola; Rooney, James F; Rinehart, Alex R; Cohen, Myron S; McCauley, Marybeth; Grinsztejn, Beatriz
Source
In The Lancet HIV December 2023 10(12):e767-e778
Subject
Language
ISSN
2352-3018